Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation

Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
Author :
Publisher : Karger Medical and Scientific Publishers
Total Pages : 39
Release :
ISBN-10 : 9783318072778
ISBN-13 : 331807277X
Rating : 4/5 (77X Downloads)

Book Synopsis Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation by : A.-M. Baird

Download or read book Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation written by A.-M. Baird and published by Karger Medical and Scientific Publishers. This book was released on 2023-03-09 with total page 39 pages. Available in PDF, EPUB and Kindle. Book excerpt: Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called ‘metastatic’. New lung cancer treatments are being developed that directly target the gene mutations that control how cancers grow and spread. The most important gene mutations in cancer are called ‘driver mutations’. In NSCLC, this includes KRAS mutations, which can be used as targets for treatment. There are new treatments designed for lung cancers with a KRAS mutation that are already available. And more are being developed. Treatments in development are tested in clinical trials. There are several different phases of clinical trials that people with cancer can take part in. This booklet aims to help patients with NSCLC understand their options so that they can talk to their doctors, nurses, and medical team about their cancer and its treatment. Table of Contents: • What is non-small cell lung cancer? • How can lung cancer develop? • What is metastatic NSCLC? • More about genes and cancer • Oncogenes and cancer • Driver mutations and biomarkers • How your doctor knows your cancer is KRAS-positive • More about KRAS • What does having a KRAS-positive cancer mean for me? • Talking to your doctor about your treatment • About clinical trials and research • Finding further information and support


Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation Related Books

Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
Language: en
Pages: 39
Authors: Anne-Marie Baird
Categories: Medical
Type: BOOK - Published: 2023-03-31 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A can
Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
Language: en
Pages: 39
Authors: A.-M. Baird
Categories: Medical
Type: BOOK - Published: 2023-03-09 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A can
Fast Facts: Non-Small-Cell Lung Cancer
Language: en
Pages: 148
Authors: Mary O'Brien
Categories: Medical
Type: BOOK - Published: 2022-02-28 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Despite an overall decrease in tobacco use, lung cancer (80–85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in
Fast Facts for Patients: Colorectal Cancer with KRAS Mutation
Language: en
Pages: 41
Authors: Rona Yaeger
Categories: Medical
Type: BOOK - Published: 2024-03-20 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Colorectal cancer (CRC) is cancer that begins in the colon or rectum of the digestive system. KRAS is a protein that sends signals to cells telling them to divi
Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners
Language: en
Pages: 120
Authors: Marianne Davies
Categories: Medical
Type: BOOK - Published: 2019-07-16 - Publisher: Springer

DOWNLOAD EBOOK

This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patient